ERBB2 and breast cancer: Yakes et al. and Le et al. demonstrated that the reduction of p27 levels in SKBR3 HER2+ BC cells by antisense oligonucleotides[64] or by small interfering RNA[63] blocked the growth arrest mediated by trastuzumab.